Found: 53
Select item for more details and to access through your institution.
microRNA‐messenger RNA regulatory network of esophageal squamous cell carcinoma and the identification of miR‐1 as a biomarker of patient survival.
- Published in:
- Journal of Cellular Biochemistry, 2019, v. 120, n. 8, p. 12259, doi. 10.1002/jcb.28166
- By:
- Publication type:
- Article
Association of previously irradiated stable brain metastases with outcomes of atezolizumab‐treated non‐small cell lung cancer: A pooled analysis of individual patient data from three randomized trials.
- Published in:
- Cancer Communications, 2024, v. 44, n. 2, p. 278, doi. 10.1002/cac2.12512
- By:
- Publication type:
- Article
Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial.
- Published in:
- Radiation Oncology, 2014, v. 9, n. 1, p. 1, doi. 10.1186/1748-717X-9-108
- By:
- Publication type:
- Article
Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Outcomes for Surgery in Stage IA Large Cell Lung Neuroendocrine Compared With Other Types of Non-Small Cell Lung Cancer: A Propensity Score Matching Study Based on the Surveillance, Epidemiology, and End Results (SEER) Database.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.572462
- By:
- Publication type:
- Article
Treatment of stage IIIA/B non-small-cell lung cancer in era of immunotherapy: Perspective of radiotherapy.
- Published in:
- Journal of Practical Oncology, 2023, v. 38, n. 2, p. 110, doi. 10.13267/j.cnki.syzlzz.2023.019
- By:
- Publication type:
- Article
Rationale and value of consolidative cranial local therapy in EGFR-mutant non-small cell lung cancer patients with baseline brain metastasis treated with first-line EGFR-TKIs.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231169975
- By:
- Publication type:
- Article
Predicting the Value of Adjuvant Therapy in Esophageal Squamous Cell Carcinoma by Combining the Total Number of Examined Lymph Nodes with the Positive Lymph Node Ratio.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 8, p. 2367, doi. 10.1245/s10434-019-07489-3
- By:
- Publication type:
- Article
Liquid-based cell suspension of supraclavicular lymph node fine-needle aspirate as an alternative specimen for NGS-based genomic profiling in advanced lung cancer.
- Published in:
- Clinical & Translational Medicine, 2020, v. 10, n. 6, p. 1, doi. 10.1002/ctm2.196
- By:
- Publication type:
- Article
Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Optimal timing and clinical value of radiotherapy in advanced ALK-rearranged non-small cell lung cancer with or without baseline brain metastases: implications from pattern of failure analyses.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Recommendation for the definition of postoperative radiotherapy target volume based on a pooled analysis of patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma-the ESO-shanghai 1 trial protocol.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A Phase II Study of Apatinib in Patients with Chemotherapy‐Refractory Esophageal Squamous Cell Carcinoma (ESO‐Shanghai 11).
- Published in:
- Oncologist, 2021, v. 26, n. 6, p. e925, doi. 10.1002/onco.13668
- By:
- Publication type:
- Article
Immunotherapy progress and clinical strategy of unresectable locally advanced non-small cell lung cancer.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1022042
- By:
- Publication type:
- Article
Cumulative incidence and risk factors of brain metastases in metastatic non–small cell lung cancer without baseline brain metastasis: Pooled analysis of individualized patient data from IMpower130, IMpower131, and IMpower150.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 15, p. 2601, doi. 10.1002/cncr.35242
- By:
- Publication type:
- Article
Combination of Radiation Therapy and Immunotherapy for Non-small Cell Lung Cancer: Peer Exchange on Frontier Academic Topics.
- Published in:
- Chinese Journal of Lung Cancer, 2020, v. 23, n. 6, p. 532, doi. 10.3779/j.issn.1009-3419.2020.102.24
- By:
- Publication type:
- Article
Lymphocyte recovery from radiation-induced lymphopenia in locally advanced esophageal squamous cell carcinoma: correlations with prognosis and lymphocyte-related organs.
- Published in:
- Radiation Oncology, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13014-023-02354-w
- By:
- Publication type:
- Article
Stereotactic ablative radiotherapy: A potentially curable approach to early stage multiple primary lung cancer.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 18, p. 3402, doi. 10.1002/cncr.28217
- By:
- Publication type:
- Article
Clinical outcomes of advanced non-small cell lung cancer patients harboring distinct subtypes of EGFR mutations and receiving first-line tyrosine kinase inhibitors: brain metastasis and de novo T790M matters.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Long‐term outcome of definitive radiotherapy for locally advanced non‐small cell lung cancer: A real‐world single‐center study in the pre‐durvalumab era.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 15, p. 1, doi. 10.1002/cam4.70051
- By:
- Publication type:
- Article
Pattern of failure and clinical value of local therapy for oligo‐recurrence in locally advanced non‐small cell lung cancer after definitive chemoradiation: Impact of driver mutation status.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 6, p. 6971, doi. 10.1002/cam4.5493
- By:
- Publication type:
- Article
Low‐ dose Apatinib promotes vascular normalization and hypoxia reduction and sensitizes radiotherapy in lung cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 4, p. 4434, doi. 10.1002/cam4.5113
- By:
- Publication type:
- Article
Real World Experience of Crizotinib in 104 Patients With ALK Rearrangement Non-small-cell Lung Cancer in a Single Chinese Cancer Center.
- Published in:
- Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01116
- By:
- Publication type:
- Article
Sintilimab in combination with stereotactic body radiotherapy and granulocyte-macrophage colony-stimulating factor in metastatic non-small cell lung cancer: The multicenter SWORD phase 2 trial.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-51807-7
- By:
- Publication type:
- Article
Identification and Integrated Analysis of circRNA and miRNA of Radiation-Induced Lung Injury in a Mouse Model.
- Published in:
- Journal of Inflammation Research, 2021, v. 14, p. 4421, doi. 10.2147/JIR.S322736
- By:
- Publication type:
- Article
Number of Negative Lymph Nodes is Associated with Survival in Thoracic Esophageal Squamous Cell Carcinoma Patients Undergoing Three-Field Lymphadenectomy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2014, v. 21, n. 9, p. 2857, doi. 10.1245/s10434-014-3665-y
- By:
- Publication type:
- Article
Nodal Skip Metastasis is not a Predictor of Survival in Thoracic Esophageal Squamous Cell Carcinoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2013, v. 20, n. 9, p. 3052, doi. 10.1245/s10434-013-2987-5
- By:
- Publication type:
- Article
A review of the application of oil analysis in condition monitoring and life prediction of wind turbine gearboxes.
- Published in:
- Insight: Non-Destructive Testing & Condition Monitoring, 2021, v. 63, n. 5, p. 289, doi. 10.1784/insi.2021.63.5.289
- By:
- Publication type:
- Article
Prognostic value of genomic mutation signature associated with immune microenvironment in southern Chinese patients with esophageal squamous cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 8, p. 1, doi. 10.1007/s00262-024-03725-2
- By:
- Publication type:
- Article
Oligo-residual disease in PD-1/PD-L1 inhibitor-treated metastatic non-small cell lung cancer: incidence, pattern of failure, and clinical value of local consolidative therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 8, p. 1, doi. 10.1007/s00262-024-03720-7
- By:
- Publication type:
- Article
A brief report on incidence, radiographic feature and prognostic significance of brain MRI changes after anti-PD-1/PD-L1 therapy in advanced non-small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 5, p. 1275, doi. 10.1007/s00262-021-03070-8
- By:
- Publication type:
- Article
Long-Term Results of a Phase 2 Study of Definitive Chemoradiation Therapy Using S-1 for Esophageal Squamous Cell Carcinoma Patients Who Were Elderly or With Serious Comorbidities.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.839765
- By:
- Publication type:
- Article
Is Performance of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography/Computed tomography (CT) or Contrast-enhanced CT Efficient Enough to Guide the Hilar Lymph Node Staging for Patients with Esophageal Squamous Cell Carcinoma?
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.814238
- By:
- Publication type:
- Article
Mechanisms and Implications of CDK4/6 Inhibitors for the Treatment of NSCLC.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.676041
- By:
- Publication type:
- Article
A "Seed-and-Soil" Radiomics Model Predicts Brain Metastasis Development in Lung Cancer: Implications for Risk-Stratified Prophylactic Cranial Irradiation.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 307, doi. 10.3390/cancers15010307
- By:
- Publication type:
- Article
Atypical Response in Metastatic Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors: Radiographic Patterns and Clinical Value of Local Therapy.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 180, doi. 10.3390/cancers15010180
- By:
- Publication type:
- Article
Plasma Extracellular Vesicle Long RNA in Diagnosis and Prediction in Small Cell Lung Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 22, p. 5493, doi. 10.3390/cancers14225493
- By:
- Publication type:
- Article
LncRNA-RP11 Modulates TGF-β1-Activated Radiation-Induced Lung Injury Through Downregulating microRNA-29a.
- Published in:
- Dose-Response, 2020, v. 18, n. 4, p. 1, doi. 10.1177/1559325820949071
- By:
- Publication type:
- Article
Identification of lncRNA, MicroRNA, and mRNA-Associated CeRNA Network of Radiation-Induced Lung Injury in a Mice Model.
- Published in:
- Dose-Response, 2019, v. 17, n. 4, p. N.PAG, doi. 10.1177/1559325819891012
- By:
- Publication type:
- Article
A novel angular dependency model for MatriXX response and its application to true composite dose verification for IMRT plans.
- Published in:
- Journal of Applied Clinical Medical Physics, 2021, v. 22, n. 10, p. 120, doi. 10.1002/acm2.13405
- By:
- Publication type:
- Article
Comparison of 3 Paclitaxel-Based Chemoradiotherapy Regimens for Patients With Locally Advanced Esophageal Squamous Cell Cancer: A Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 2, p. e220120, doi. 10.1001/jamanetworkopen.2022.0120
- By:
- Publication type:
- Article
Regulatory T Cells: An Emerging Player in Radiation-Induced Lung Injury.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.01769
- By:
- Publication type:
- Article
Overall survival benefit of osimertinib and clinical value of upfront cranial local therapy in untreated EGFR‐mutant nonsmall cell lung cancer with brain metastasis.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 8, p. 1318, doi. 10.1002/ijc.33904
- By:
- Publication type:
- Article
Phosphorylated AKT1 is associated with poor prognosis in esophageal squamous cell carcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2015, v. 34, n. 1, p. 1, doi. 10.1186/s13046-015-0212-z
- By:
- Publication type:
- Article
Phosphorylated AKT1 is associated with poor prognosis in esophageal squamous cell carcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2015, v. 34, n. 1, p. 1, doi. 10.1186/s13046-015-0212-z
- By:
- Publication type:
- Article
Sintilimab, stereotactic body radiotherapy and granulocyte-macrophage colony stimulating factor as second-line therapy for advanced non-small cell lung cancer: safety run-in results of a multicenter, single-arm, phase II trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The value of local consolidative therapy in Osimertinib-treated non-small cell lung cancer with oligo-residual disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The value of local consolidative therapy in Osimertinib-treated non-small cell lung cancer with oligo-residual disease.
- Published in:
- Radiation Oncology, 2020, v. 15, n. 1, p. N.PAG, doi. 10.1186/s13014-020-01651-y
- By:
- Publication type:
- Article
Crizotinib in Chinese Patients with ROS1-Rearranged Advanced Non‒Small-Cell Lung Cancer in Routine Clinical Practice.
- Published in:
- 2019
- By:
- Publication type:
- journal article